Skip to main content

Supply report · October 2026 register copy

Epilepsy in Nigeria: the registration data

Across the 3 epilepsy molecules Ogbogwu tracks, our October 2026 copy of the NAFDAC Greenbook lists 25 active registrations held by 19 companies — plus 21 registrations recorded as no longer active. Every figure on this page is quoted from that dated copy; the register can change after our copy is taken.

Active registrations
25
Companies
19
New in the last 12 months
3
Renewals due within a year
0

Who holds the registrations

The ten companies with the most active epilepsy registrations in our copy. The registrant is the NAFDAC applicant of record — for imported lines this is often the Nigerian distributor, not the factory.

  1. 1.Novartis Nigeria— 3 active
  2. 2.GlaxoSmithKline— 2 active
  3. 3.Maydon Pharmaceuticals— 2 active
  4. 4.Phillips Pharmaceuticals (Nigeria)— 2 active
  5. 5.Ranbaxy Nigeria— 2 active
  6. 6.Bfifcy Pharmaceuticals— 1 active
  7. 7.Chez Resources Pharmaceutical— 1 active
  8. 8.De - Godstime Industry— 1 active
  9. 9.Getz Pharma Nigeria— 1 active
  10. 10.Great Timec Pharma Nigeria— 1 active

Where the products are made

Maker country as the register records it, across the 25 active registrations.

  • India— 13 (52%)
  • China— 3 (12%)
  • Italy— 3 (12%)
  • Belgium— 2 (8%)
  • France— 1 (4%)
  • Malaysia— 1 (4%)
  • Nigeria— 1 (4%)
  • Pakistan— 1 (4%)

Dosage forms

  • Tablet— 23 active
  • Caplet— 1 active
  • Film coated tablet— 1 active

Newest registrations

The latest epilepsy approvals in our copy — 3 products were registered in the twelve months to October 2026.

  • Bfifcy Carbamazepine Tablets 200 mg — C4-0935, approved 2025-11-26
  • Carbamal 400- CR Tablet — A4-0613, approved 2025-11-26
  • Carbamazepine Tablets BP 200 mg — A4-101741, approved 2025-11-26

All new registrations, updated monthly →

The molecules behind these numbers

“Epilepsy” on this page means these molecules — the register itself has no therapeutic grouping, so a category page must say exactly what it counted.

The most-supplied presentations

Manufacturing or exporting epilepsy medicines?

This is the market you'd be entering. See what NAFDAC registration and import into Nigeria require, and talk to us about distribution.

Supply the Nigerian market

Other supply reports

This page quotes the public NAFDAC Greenbook as of our dated copy, across the molecules Ogbogwu tracks in this category. It is a record of registrations, not market-share or sales data, and not an endorsement of any product. Registration status can change; for decisions that matter, confirm on the official Greenbook.